For Industry - for development in Japan

• Why Japan for drug development Vol.2 (presentation for ENDPOINTS Events on May 21^st, 2025)[2.4MB]
  • ENDPOINTS Events on-Demand Session: Taking the next steps with your drug in Japan (May 21^st, 2025) (external link)

Note: Registration (free of charge) is required to view the videos.

• Why Japan for drug development Vol.1 (presentation for ENDPOINTS Events on November 14^th, 2024)[2.6MB]
  • ENDPOINTS Events on-Demand Session : Developing your new medicine in Japan faster (November 14^th, 2024) (external link)​

Note: Registration (free of charge) is required to view the videos.

• PMDA’s Support to Venture Companies[2.3MB]
• Doing business in Japan: What is attracting?[1.4MB]
• PMDA’s Activities Leading to Medical Device Innovation[3.2MB]
• Supports from Japanese government (MHLW)(PDF)[1.4MB] (external link)

• Frequently Asked Questions (FAQ)
• PMDA Updates

• Ministry of Health, Labour and Welfare (MHLW)
  • Medical Innovation Support Office (MEDISO)
• Japan Agency for Medical Research and Development (AMED)
• National Institutes of Biomedical Innovation, Health and Nutrition(NIBN)
  • Orphan Products Development Support Program
• Ministry of Economy, Trade and Industry (METI)
  • Healthcare Innovation Hub (InnoHub)
• Japan External Trade Organization (JETRO)
• Cabinet Secretariat : Council of the Concept for Early Prevalence of the Novel Drugs to Patients by Improving Drug Discovery Capabilities

• Japan Pharmaceutical Manufacturers Association (JPMA)
• Pharmaceutical Research and Manufacturers of America (PhRMA)
• European Federation of Pharmaceutical Industries and Associations, Japan (EFPIA Japan)
• The Japan Federation of Medical Devices Associations (JFMDA)
• American Medical Devices and Diagnostics Manufacturers' Association (AMDD)
• EUROPEAN BUSINESS COUNCIL IN JAPAN (EBC)
• Advanced Medical Technology Association (AdvaMed)
• Forum for Innovative Regenerative Medicine (FIRM)
• Japan CRO Association (JCROA)